RxDoctor Payments Data

Brayton Shirley, MD

Orthopaedic Surgery · Greer, SCNPI 1205890555

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,450 of the $3,696 with a category attached, or 66.3%. Conformis, Inc. accounts for 67.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $2,613 and has fallen 97.5% since, to $65 in 2025.

$3,696in general payments, 2019–2025

Across 28 payments — averaging $132.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Conformis, Inc.$2K
  • Smith+Nephew$879
  • Onkos Surgical, Inc.$125
  • Zimmer Biomet$103
  • Innovation Technologies Inc$100
$130,200in research payments, 2019–2025

Across 17 payments — averaging $7658.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$130K

What the payments were for

  • Speaking & faculty fees$2,45066%
  • Food & beverage$1,24634%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,696 in reported general payments places this provider in the 55th percentile of 325 orthopaedic surgery providers in South Carolina.

See all orthopaedic surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$440,042
Medicare patients
740
Services billed
5,215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib148$3,468
Doxycycline Hyclate19$1,458
Dexamethasone47$331
Diclofenac Sodium28$268
Amoxicillin159$207
Meloxicam93$201
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$113
Gabapentin24$103
Tramadol Hcl27$75
Naproxen15$58
Prednisone28$53
Cyclobenzaprine Hcl14$50
Clindamycin Hcl39$48
Hydromorphone Hcl12$33
Cefadroxil13$33

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Greer

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →